Atellica® VTLi Patient-side Immunoassay Analyzer

A vital leap forward in cardiac testing

Speed and accuracy where it matters most—the wait over for hs-cTnI at the point of care. 

When lives are at stake and every second is crucial, how can clinicians get the answers they need quickly? Every lost second in the emergency department has the potential to affect patient outcomes. The Atellica® VTLi Patient-side Immunoassay Analyzer provides the vital information clinicians need to aid in making decisions about patient disposition.
When ruling out a potential myocardial infarction (MI), every minute spent waiting on test results comes at a cost. Patients and their families are anxious, and clinicians and laboratory professionals are pressured to identify the problem quickly and accurately. Increased time to results adds congestion to an already busy emergency department. But what if ED staff had access to high-sensitivity troponin right at the point of care? Consider the value of adding a new tool at the clinician’s disposal that can provide high-sensitivity troponin I (hs-cTnI) results in just 8 minutes from a single fingerstick and patient interaction. The solution is intuitive, easily integrates into the existing workflow, and gives laboratory partners centralized control over decentralized testing, so ED throughput can be improved for efficiency and confidence.
 The Atellica VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, will transform your chest pain assessment process to benefit patients, clinicians, and your operational workflow. Because when it comes to assessing patients with symptoms of an MI in the ED, trust, time, and resources aren’t just valuable - they’re vital.


The Atellica VTLi system streamlines chest pain assessment, aiding in earlier disposition decisions for patients not having an MI and fast interventions for those who are.

POC AtellicaVTLi CartridgeBack 2865 Reflection

The Atellica VTLi system offers hs-cTnI testing right at the point of care. Results are available in just minutes for clinicians and laboratory partners.

POC AtellicaVTLi ED Doctor Nurse Patient

The Atellica VTLi system will aid in transforming your chest pain assessment process to benefit patients, clinicians, and operational workflow.

Each year millions of patients enter emergency departments presenting with symptoms of acute coronary syndrome (ACS).1 Determining the differential diagnosis of these patients takes time, and that time comes at a human cost: the anxiety felt by patients and their families as they wait for answers and pressure on the medical staff to identify the problem as quickly and accurately as possible.2 Our development goal is to provide high-sensitive troponin testing where it matters most—at the point of care. The design goal of the Atellica POC system is to enable ED staff to allocate resources to patients quicker and with more confidence.

Atellica Cartridge BackClinical Value of hs-cTnlCartridge DesignStreamlined Patient Testing WorkflowTroponin: High-Sensitivity vs. Contemporary
  1. Atellica VTLi

    • Elevations greater than 5 times the URL have high (90%) PPV for acute type 1 MI.
    • Elevations up to 3 times the URL have limited (50–60%) PPV for AMI.
    • It is common to detect circulating levels of cardiac troponin in healthy people.

  2. Reagent cartridge top view
  3. The cartridge is disposable (single-use) and specific for one or more assays, with no warm-up time from refrigerated storage.
  4. Each disposable cartridge is identified by a unique Radio Frequency identification (RFID) chip, that contains information on the type of test, calibration data, and lot-specific information.
  5. Instructs the instrument to automatically starts the correct assay protocol Integrated assay quality control in every cartridge
  • Operator scans ID.
    • Sample type flexibility: The system can produce results on lithium-heparin whole blood, lithium-heparin plasma, and capillary samples.
    • Sample volume: minimum of 30 µL of blood required to perform the test.
    • Test results are sent securely through our POC Ecosystem™ Solution via WI-FI or Ethernet for storage in the LIS/HIS and EMR.
  • Atellica cardiac chart

    • Contemporary assays must detect cTn in 20% to <50% of healthy individuals.
    • High-sensitivity assays must detect cTn in at least 50% of healthy individuals and must have <10% CV at the 99th percentile of normal.
    • Units of measure:
    • Contemporary: ng/mL
    • High-sensitivity: ng/L     
  • Related sessions